HealthMap

Dr. Ronald Roth's Nutritional and Biochemical Perspective on ALS and FUS

• Metabolic and Nutritional Context: From the perspective of Acu-Cell Nutrition, diseases such as Amyotrophic Lateral Sclerosis (ALS) are rarely viewed through the lens of a single genetic defect in isolation, but rather through how biochemical imbalances, mineral antagonisms, and oxidative stress influence cellular function and gene expression.
• The Role of the FUS Gene: The FUS (Fused in Sarcoma) gene normally encodes an RNA-binding protein primarily localized in the nucleus, where it is involved in transcription and RNA processing.
• Specific Pathological Mutations: While numerous mutations in the FUS gene are linked to familial ALS, mutations that alter the nuclear localization signal (NLS)—located at the extreme C-terminus of the protein—are particularly critical.
• Disruption of Nuclear Transport:
• Mutations in the NLS region impair the ability of transport receptors (specifically transportin/karyopherin beta-2) to recognize and import FUS back into the nucleus.
• Consequently, mutant FUS accumulates abnormally in the cytoplasm rather than fulfilling its nuclear duties.
• This cytoplasmic mislocalization leads to the formation of toxic protein aggregates and directly disrupts normal nucleocytoplasmic transport of vital RNA and proteins, ultimately contributing to motor neuron degeneration.
• Biochemical and Environmental Interplay: While the genetic mutation initiates the structural defect, Acu-Cell principles emphasize that the rate of disease progression, cellular toxicity, and neurodegeneration are heavily modulated by:
• Oxidative stress and free radical damage.
• Imbalances in essential trace minerals (such as zinc, copper, and selenium) that affect antioxidant enzyme systems like superoxide dismutase (SOD).
• Cellular energy production and mitochondrial efficiency.